Completed PHASE1 INTERVENTIONAL NCT00755924

Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein

Sponsor: HealthPartners Institute

Updated 5 times since 2017 Last updated: Nov 25, 2015 Started: Jun 30, 2008 Primary completion: Aug 31, 2009 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00755924, this PHASE1 trial focuses on Cholesterol, HDL and remains completed. Sponsored by HealthPartners Institute, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HealthPartners Institute

Data source: HealthPartners Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States